Sherlock Biosciences, Inc., a pioneering force in the biotechnology sector, is headquartered in the United States. Founded in 2019, the company has rapidly established itself as a leader in the development of CRISPR-based diagnostic tools and solutions. With a focus on revolutionising molecular diagnostics, Sherlock Biosciences offers unique products that leverage advanced CRISPR technology for rapid and accurate detection of pathogens and genetic mutations. The company’s flagship offerings, including the Sherlock™ platform, stand out for their precision and ease of use, catering to both clinical and research applications. Notable achievements include significant partnerships and collaborations that enhance its market position, making Sherlock Biosciences a key player in the evolving landscape of healthcare innovation. With a commitment to improving global health outcomes, the company continues to push the boundaries of what is possible in diagnostics.
We don't have data for Sherlock Biosciences, Inc., but we can show you information about their parent organization instead.
View parent company